These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7105524)

  • 1. The effect of node sample size on the histological node status in patients with operable breast cancer.
    Black RB; Steele RJ; Collins WC; Roberts MM; Stewart HJ; Forrest AP
    Clin Oncol; 1982 Jun; 8(2):137-43. PubMed ID: 7105524
    [No Abstract]   [Full Text] [Related]  

  • 2. Site size and significance of palpable metastatic and 'reactive' nodes in operable breast cancer.
    Black RB; Steele RJ; Collins WC; Forrest AP
    Clin Oncol; 1982 Jun; 8(2):127-35. PubMed ID: 7105523
    [No Abstract]   [Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False negative sentinel node procedure established through palpation of the biopsy wound.
    Tanis PJ; Nieweg OE; Merkus JW; Peterse JL; Kroon BB
    Eur J Surg Oncol; 2000 Nov; 26(7):714-5. PubMed ID: 11078620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How representative is a lymph node biopsy from the axilla in a node-negative breast cancer patient?
    Hartveit F
    Clin Oncol; 1981 Dec; 7(4):303-9. PubMed ID: 7318274
    [No Abstract]   [Full Text] [Related]  

  • 8. Axillary lymph node status of T1 primary breast cancer in a diverse population.
    Madan AK; Macareo L; Winfrey K; Beech DJ
    Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY; Mouret E; Diéras V; Laurence V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Vincent-Salomon A; Scholl S; Extra JM; Asselain B; Pouillart P
    Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph nodes in the tail of the breast can be missed in standard axillary dissection.
    Williams RN; Jones L; Stotter A
    Eur J Surg Oncol; 2009 Mar; 35(3):271-5. PubMed ID: 18407454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
    Laura S; Coombs NJ; Ung O; Boyages J
    ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of palpation as basis for decision on lymph node excision].
    Bakholdt VT; Løntoft E; Pedersen NB
    Ugeskr Laeger; 1998 Aug; 160(33):4776-8. PubMed ID: 9715660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.